From January 1, 2024 to March 31, 2024, the company has repurchased 1,521,975 shares, representing 0.37% for CNY 23.86 million. With this, the company has completed the repurchase of 1,521,975 shares, representing 0.37% for CNY 23.86 million under the buyback announced on December 27, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.22 CNY | -2.39% |
|
-8.99% | -49.28% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-49.28% | 577M | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
+10.74% | 25.92B | |
-13.50% | 26.03B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B | |
-12.61% | 10.64B |
- Stock Market
- Equities
- 688046 Stock
- News GemPharmatech Co., Ltd.
- Tranche Update on GemPharmatech Co., Ltd.'s Equity Buyback Plan announced on December 27, 2023.